Accueil / Communiqués

Communiqués

Lygos Secures Strategic Investment from CJ CheilJedang to Accelerate Growth in Bioengineering Industries

Monday, September 16th 2019 at 12:00pm UTC Top Korean food and biotech manufacturer reinforces commitment to increasing efficiency of more sustainable, scalable and cost-effective biotechnology production solutions BERKELEY, Calif.–(BUSINESS WIRE)– Lygos, Inc., a full-stack producer of specialty chemicals that deliver high-value performance without environmental toxicity, today announced that CJ CheilJedang …

Plus »

Seattle Genetics and Astellas Announce U.S. FDA Grants Priority Review for Enfortumab Vedotin Biologics License Application in Locally Advanced or Metastatic Urothelial Cancer

Monday, September 16th 2019 at 12:00pm UTC – Food & Drug Administration Sets Prescription Drug User Fee Action Date for March 15, 2020 – BOTHELL, Wash. & TOKYO–(BUSINESS WIRE)– Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced that the …

Plus »

Results from Blue Earth Diagnostics’ FALCON Trial Show 64% of Patients with Suspected Recurrent Prostate Cancer Had Change in Management Following Axumin® (Fluciclovine F 18) PET/CT Scan

Monday, September 16th 2019 at 12:30pm UTC ? Results presented at ASTRO Annual Meeting evaluate clinical utility of 18F-fluciclovine PET/CT imaging in men with recurrent prostate cancer ? BURLINGTON, Mass. & OXFORD, England–(BUSINESS WIRE)– Blue Earth Diagnostics, a Bracco company focused on molecular imaging diagnostics, today announced results from an …

Plus »

Tiziana Life Sciences Announces FDA Approval to Initiate Phase I Clinical Trial with Orally Administered Foralumab in Healthy Volunteers

Monday, September 16th 2019 at 11:44am UTC A breakthrough approach for treatment of autoimmune and inflammatory diseases LONDON–(BUSINESS WIRE)– THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULATION (596/2014). UPON PUBLICATION OF THE ANNOUNCEMENT VIA A …

Plus »

Ancora Heart Announces Key Activities for Transcatheter Cardiovascular Therapeutics 2019

Monday, September 16th 2019 at 12:00pm UTC Interim study results will be presented on systolic heart failure patients treated with percutaneous therapy designed to improve left ventricular function SANTA CLARA, Calif.–(BUSINESS WIRE)– Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced the company’s key …

Plus »

Ayala Pharmaceuticals to Present at 2019 Ladenburg Thalmann Healthcare Conference

Monday, September 16th 2019 at 12:00pm UTC REHOVOT, Israel & WILMINGTON, Del.–(BUSINESS WIRE)– Ayala Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people living with genetically defined cancers, today announced that Roni Mamluk, Ph.D., Chief Executive Officer of Ayala, will present at the 2019 Ladenburg …

Plus »

Alnylam Pharmaceuticals Announces Initiation of APOLLO-B Phase 3 Study of Patisiran for the Treatment of Transthyretin Amyloidosis with Cardiomyopathy

Monday, September 16th 2019 at 11:30am UTC – APOLLO-B Will Enroll Patients with Both Hereditary and Wild-Type Amyloidosis – CAMBRIDGE, Mass.–(BUSINESS WIRE)– Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the Company has initiated APOLLO-B, a global Phase 3 placebo-controlled clinical trial of patisiran, an …

Plus »

AlivaMab Discovery Services Announces Multi-Target Agreement with Janssen

Monday, September 16th 2019 at 11:00am UTC ADS to provide expertise and capabilities in antibody drug discovery SAN DIEGO–(BUSINESS WIRE)– class= »bwalignl »> AlivaMab Discovery Services, LLC, a company providing custom human therapeutic antibody drug discovery services using the AlivaMab™ Mouse, a best-in-class antibody discovery platform, today announced a multi-target discovery agreement …

Plus »

NovaBay Pharmaceuticals Names Finance Executive Jeff Zheng to its Board of Directors

Monday, September 16th 2019 at 10:50am UTC EMERYVILLE, Calif.–(BUSINESS WIRE)– NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, announces that Yenyou (Jeff) Zheng, Ph.D. has joined the Company’s board as an independent director. Dr. Zheng will chair the nominating …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.